Dry Eye Disease- Pharmacy Technician

  Price  $6.95

  Credits  1.5

Clear


Format
Dry eye disease (DED) is a chronic, progressive, inflammatory disease of the ocular surface and lacrimal glands. The American Academy of Ophthalmology describes DED as inadequate moisture in the eyes due to changes in tear film consistency and the type of tears produced (leading to evaporative loss), with or without decreased tear production. The disease is also known as keratoconjunctivitis sicca, ocular surface disease, and dry eye syndrome. Nearly 12 million people in the US are coping with dry eye symptoms on a daily basis. The prevalence of DED among adults in the US is approximately 14%. The disease occurs twice as often in women, and increases in prevalence with age (3% at 35 years and nearly 19% at 75 years or older). Many factors contribute to DED. It has been linked with various autoimmune diseases (eg, Sjogren’s syndrome, lupus, rheumatoid arthritis), diabetes, and thyroid disorders. DED has also been associated with blepharitis and rosacea. In addition, eyelids that are turned in (entropion) or out (ectropion) can result in DED. Postmenopausal women are at high risk for DED – most likely due to hormonal changes resulting in a reduced ophthalmic antiinflammatory response and decreased lacrimal secretions. Dry eye disease takes its toll on patients economically and on their quality of life. Symptoms range from stinging, irritation, ocular fatigue, to variations in visual acuity. These can occur for extended periods of time and significantly impact a person’s daily activities. In a 2016 report on the humanistic and economic impact of DED in the US, the annual direct cost for managing the disease was estimated at $3.8 billion dollars....
$6.95

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Tech Drug Therapy

Author
Celia MacDonnell
BS Pharm, PharmD
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

  • List the major medication classes that are used to treat patients suffering from dry eyes. Recognize which medications are available without a prescription.
  • List the anti-inflammatory medications that may be used to treat moderate to severe dry eye disease. State the brand and generic names for these medications and describe their major side effects.
  • Recognize the recommended administration and dosing for medications commonly used to treat dry eye disease.

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
    20-878486
  • Universal Activity Number:
    Pharmacy Technician : 0798-0000-21-209-H01-T
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.